| Identification | Back Directory | [Name]
L-arabino-Heptitol, 3,7-anhydro-1,4,5,6-tetradeoxy-6-[[(6,7-dihydro[1,4]oxathiino[2,3-c]pyridazin-3-yl)methyl]amino]-1-(3-fluoro-6-methoxy-1,5-naphthyridin-4-yl)- | [CAS]
1229514-11-7 | [Synonyms]
ACT387042
ACT-387042
L-arabino-Heptitol, 3,7-anhydro-1,4,5,6-tetradeoxy-6-[[(6,7-dihydro[1,4]oxathiino[2,3-c]pyridazin-3-yl)methyl]amino]-1-(3-fluoro-6-methoxy-1,5-naphthyridin-4-yl)- | [Molecular Formula]
C23H26FN5O4S | [MOL File]
1229514-11-7.mol | [Molecular Weight]
487.55 |
| Hazard Information | Back Directory | [Description]
ACT-387042 is a Bacterial Topoisomerase Inhibitor. with broad-spectrum activity against Gram-positive and -negative bacteria, including methicillin-resistant Staphylococcus aureus and penicillin- and fluoroquinolone-resistant Streptococcus pneumoniae. | [Uses]
ACT-387042 is a bacterial topoisomerase inhibitor with broad-spectrum activity against Gram-positive and Gram-negative bacteria, including methicillin-resistant Staphylococcus aureus and penicillin- and fluoroquinolone-resistant Streptococcus pneumoniae [1]. | [References]
[1] In Vivo Pharmacodynamic Target Investigation of Two Bacterial Topoisomerase Inhibitors, ACT-387042 and ACT-292706, in the Neutropenic Murine Thigh Model against Streptococcus pneumoniae and Staphylococcus aureus |
|
|